Results 31 to 40 of about 3,978,530 (165)

Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial [PDF]

open access: yesCommunications Medicine
Background Psilocybin-assisted therapy (PAT) shows promise for treating PTSD in adults but hasn’t been studied in U.S. military Veterans, who face higher symptom severity and suicide risk.
Stacey B. Armstrong   +7 more
doaj   +2 more sources

Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial [PDF]

open access: yesBMC Psychiatry
Background A significant number of individuals with alcohol use disorder remain unresponsive to currently available treatments, which calls for the development of new alternatives.
Laetitia Vanderijst   +12 more
doaj   +2 more sources

Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery [PDF]

open access: yesTherapeutic Advances in Psychopharmacology
Background: Psychedelics are receiving growing interest among clinical researchers for their effects on mood and cognition. Psilocybin is one of the most widely studied classic psychedelics which has shown good safety and clinical benefit for major ...
Baeleigh VanderZwaag   +2 more
doaj   +2 more sources

Fungi for the Mind: Exploring the role of suggestion in psilocybin assisted therapy

open access: yes
This thesis explores the intersection of suggestion and psychedelic-assisted therapy (PAT), focusing specifically on the therapeutic use of psilocybin.
Clare, Susan
core   +6 more sources

The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. [PDF]

open access: yesPLoS ONE
We examined if the therapeutic alliance between study participants and intervention facilitators in a psilocybin-assisted therapy (PAT) trial changed over time and whether there were relationships between alliance, acute psilocybin experiences, and ...
Adam W Levin   +8 more
doaj   +2 more sources

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder [PDF]

open access: yesJAMA Psychiatry, 2021
Major depressive disorder (MDD) is a substantial public health burden, but current treatments have limited effectiveness and adherence. Recent evidence suggests that 1 or 2 administrations of psilocybin with psychological support produces antidepressant effects in patients with cancer and in those with treatment-resistant depression.To investigate the ...
Davis, Alan K.   +7 more
openaire   +2 more sources

Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy [PDF]

open access: yes, 2023
Background: Psilocybin, the psychoactive compound in magic mushrooms, is increasingly discussed in terms of its psychotherapeutic potential; however, little is known about community attitudes towards psilocybin assisted therapy (PAT).
Benjamin M. Ross   +3 more
core   +1 more source

Group psychedelic therapy: empirical estimates of cost-savings and improved access

open access: yesFrontiers in Psychiatry, 2023
ObjectiveTo compare group and individual psychedelic-assisted therapy in terms of clinician time, costs and patient access.MethodsUsing 2023 data from two group therapy trial sites, one using 3,4-Methylenedioxymethamphetamine (MDMA) to treat ...
Elliot Marseille   +7 more
doaj   +1 more source

The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)

open access: yes, 2020
The Yale Manual for Psilocybin-Assisted Therapy of Depression provides researchers and therapists with methods, structure, and areas to consider regarding the use of psychedelic- assisted therapy in the treatment of Major Depressive Disorder (MDD).
Jeffrey Guss   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy